Bentovim Lyron L
Transacción: 12/18/2025
COMPRA
Cambio
+3,172
Precio
$0.98
Presentación
12/19/2025
Tipo
COMPRA


Perfil cuantitativo — no constituye una recomendación de inversión.
Valoración, calidad, fortaleza financiera, momentum y datos de analistas.
Qué tan fuerte luce esta compañía para inversionistas de largo plazo
Analyst sentiment and price target
Actividad reciente de ejecutivos e insiders
| Insider | Tipo | Cambio | Precio | Transacción | Presentación |
|---|---|---|---|---|---|
| Bentovim Lyron L | COMPRA | +3,172 | $0.98 | 12/18/2025 | 12/19/2025 |
| Bentovim Lyron L | COMPRA | +10,634 | $1.15 | 12/11/2024 | 12/11/2024 |
| Bentovim Lyron L | COMPRA | +7,099 | $4.10 | 04/03/2023 | 08/26/2024 |
| Elkeles Tamar | COMPRA | +20,000 | $2.50 | 04/29/2024 | 06/04/2024 |
| Bentovim Lyron L | COMPRA | +1,780 | $1.07 | 05/24/2024 | 05/28/2024 |
| Bentovim Lyron L | COMPRA | +1,214 | $1.07 | 05/23/2024 | 05/24/2024 |
| Bentovim Lyron L | COMPRA | +2,755 | $1.07 | 05/22/2024 | 05/23/2024 |
| Bentovim Lyron L | COMPRA | +1,900 | $1.03 | 05/21/2024 | 05/22/2024 |
| RUCKDAESCHEL ALEXANDER | COMPRA | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| Gates Tyler | COMPRA | +5,532 | Not reported | 03/01/2024 | 03/05/2024 |
| Enslin Jeffrey D. | COMPRA | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| Smith David John | COMPRA | +51,480 | Not reported | 03/01/2024 | 03/05/2024 |
| Rothblum Maydan | COMPRA | +306,145 | Not reported | 03/01/2024 | 03/05/2024 |
| Charles Ian Morgan | COMPRA | +24,000 | $2.50 | 03/01/2024 | 03/05/2024 |
| Bentovim Lyron L | COMPRA | +72,153 | Not reported | 03/01/2024 | 03/05/2024 |
| Amen Lemuel | COMPRA | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| RUCKDAESCHEL ALEXANDER | VENTA | -37,778 | Not reported | 02/29/2024 | 03/05/2024 |
| Gates Tyler | VENTA | -9,216 | Not reported | 02/29/2024 | 03/05/2024 |
| Enslin Jeffrey D. | VENTA | -359,385 | Not reported | 02/29/2024 | 03/05/2024 |
| Smith David John | VENTA | -64,349 | Not reported | 02/29/2024 | 03/05/2024 |